Lynee A. Massey

Lynee A. Massey

Auto-generated profile, based on publicly available information

Lynee A. Massey

Department of Chemistry The University of Texas at San Antonio One UTSA Circle San Antonio TX 78249 USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2019 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
Kostiantyn MarichevKostiantyn Marichev
Kostiantyn Marichev
KWKan Wang
Kan Wang
KDKuiyong Dong
Kuiyong Dong
NGNicole Greco
Nicole Greco
LMLynée A. Massey
Lynée A. Massey
MDMichael Doyle
Michael Doyle

22 November 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
Kostiantyn MarichevKostiantyn Marichev
Kostiantyn Marichev
KDKuiyong Dong
Kuiyong Dong
LMLynée A. Massey
Lynée A. Massey
YDYongming Deng
Yongming Deng
LALuca De Angelis
Luca De Angelis
MDMichael Doyle
Michael Doyle
Coupling reactions of amines and alcohols are of central importance for applications in chemistry and biology. These transformations typically involve the use of a reagent, activated as an electrophile, onto which nucleophile coupling results in the formation of a carbon-nitrogen or a carbon–oxygen bond. Several promising reagents and procedures have been developed to achieve these bond forming processes in high yields with excellent stereocontrol, but few offer direct coupling without the intervention of a catalyst. Herein, we report the synthesis of chiral donor–acceptor azetines by highly enantioselective [3 + 1]-cycloaddition of enoldiazoacetates with aza-ylides and their selective coupling with nitrogen and oxygen nucleophiles via 3-azetidinones to form amino acid derivatives, including those of peptides and natural products. The overall process is general for a broad spectrum of nucleophiles, has a high degree of electronic and steric selectivity, and retains the enantiopurity of the original azetine.

24 March 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
OCOverall Coordination
Overall Coordination
SESuzanne Elsasser
Suzanne Elsasser
LELisa P. Elia
Lisa P. Elia
RMRichard I. Morimoto
Richard I. Morimoto
EPEvan Powers
Evan Powers
RNRalph A. Nixon
Ralph A. Nixon
The condition of having a healthy, functional proteome is known as protein homeostasis, or proteostasis. Establishing and maintaining proteostasis is the province of the proteostasis network, approximately 2,700 components that regulate protein synthesis, folding, localization, and degradation. The proteostasis network is a fundamental entity in biology that is essential for cellular health and has direct relevance to many diseases of protein conformation. However, it is not well defined or annotated, which hinders its functional characterization in health and disease. In this series of manuscripts, we aim to operationally define the human proteostasis network by providing a comprehensive, annotated list of its components. We provided in a previous manuscript a list of chaperones and folding enzymes as well as the components that make up the machineries for protein synthesis, protein trafficking into and out of organelles, and organelle-specific degradation pathways. Here, we provide a curated list of 838 unique high-confidence components of the autophagy-lysosome pathway, one of the two major protein degradation systems in human cells.

22 May 2017 in Angewandte Chemie
Verified
Journal Article
Closed access
PDF file
YDYongming Deng
Yongming Deng
LMLynée A. Massey
Lynée A. Massey
PZPeter Y. Zavalij
Peter Y. Zavalij
MDMichael Doyle
Michael Doyle

24 August 2017 in Angewandte Chemie
Verified
Journal Article
Closed access
PDF file
YDYongming Deng
Yongming Deng
LMLynée A. Massey
Lynée A. Massey
YNYeray A. Rodriguez Núñez
Yeray A. Rodriguez Núñez
HAHadi Arman
Hadi Arman
MDMichael Doyle
Michael Doyle

30 September 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
LYLeonard Yoon
Leonard Yoon
RBRachel C. Botham
Rachel C. Botham
AVAdriaan Verhelle
Adriaan Verhelle
CCChristian M. Cole
Christian M. Cole
ETEe Phie Tan
Ee Phie Tan
FRFulvio Reggiori
Fulvio Reggiori
Summary: Autophagy-lysosomal impairment is an early and prominent feature of neurodegeneration. Autophagy activation reduces protein aggregates and lipid level abnormalities. We performed a high-content imaging-based screen assessing 940,000 small molecules to identify those that reduce lipid droplet numbers. Of 77 validated, structurally diverse hits, 24 increased autophagy flux reporter activity, consistent with accelerated lipid droplet clearance by lipophagy. Of these, we show that CCT020312 activates autophagy independently of mammalian target of rapamycin (mTOR) inhibition, to avoid immunosuppression. CCT020312 reduced insoluble phosphorylated tau levels and tau-mediated neuronal stress vulnerability, as well as reducing intracellular Aβ levels within directly induced neurons bearing epigenetic marks of aging derived from Alzheimer’s patient fibroblasts. Moreover, CCT020312 cleared mutant prion protein aggregates and normalized trafficking deficiencies in axons of a cellular model of familial prion disease. Autophagy is widely considered a promising strategy to attenuate neurodegeneration, and here we introduce a strategy to discover new pharmacology.